Literature DB >> 1472046

Cleavage of hepatitis B virus RNA by three ribozymes transcribed from a single DNA template.

F von Weizsäcker1, H E Blum, J R Wands.   

Abstract

Hepatitis B virus is a DNA virus which replicates asymmetrically through reverse transcription of an RNA intermediate (pregenomic RNA). As a first step toward an antiviral strategy, a single synthetic oligodeoxynucleotide coding for 3 ribozyme motifs directed against three adjacent sites within the pregenomic RNA was synthesized, cloned and transcribed in vitro. Experiments utilizing 5' and 3' end labeling of RNA demonstrated that the three ribozymes accurately cleaved hepatitis B virus substrate RNA. Cleavage efficiency was similar to that of single ribozyme constructs. These results demonstrate that hepatitis B virus RNA is susceptible to ribozyme induced cleavage and illustrate that three ribozymes were simultaneously active when transcribed from a single DNA template. The expression of multiple ribozyme motifs may offer an advantage if there is high viral target sequence variability.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1472046     DOI: 10.1016/0006-291x(92)92264-x

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

1.  RNA double cleavage by a hairpin-derived twin ribozyme.

Authors:  C Schmidt; R Welz; S Müller
Journal:  Nucleic Acids Res       Date:  2000-02-15       Impact factor: 16.971

2.  Construction of HBV-specific ribozyme and its recombinant with HDV and their cleavage activity in vitro.

Authors:  Shu Juan Wen; Kai-Jun Xiang; Zhen-Hua Huang; Rong Zhou; Xue-Zhong Qi
Journal:  World J Gastroenterol       Date:  2000-06       Impact factor: 5.742

3.  Anti-HBV hairpin ribozyme-mediated cleavage of target RNA in vitro.

Authors:  Yu-Hu Song; Ju-Sheng Lin; Nan-Zhi Liu; Xin-Juan Kong; Na Xie; Nan-Xia Wang; You-Xin Jin; Kuo-Huan Liang
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

Review 4.  Gene therapeutic approaches to inhibit hepatitis B virus replication.

Authors:  Maren Gebbing; Thorsten Bergmann; Eric Schulz; Anja Ehrhardt
Journal:  World J Hepatol       Date:  2015-02-27

Review 5.  Antigene, ribozyme and aptamer nucleic acid drugs: progress and prospects.

Authors:  R A Stull; F C Szoka
Journal:  Pharm Res       Date:  1995-04       Impact factor: 4.200

6.  A ribozyme specifically suppresses transformation and tumorigenicity of Ha-ras-oncogene-transformed NIH/3T3 cell lines.

Authors:  M Y Chang; S J Won; H S Liu
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

7.  Comparative analysis of cleavage rates after systematic permutation of the NUX consensus target motif for hammerhead ribozymes.

Authors:  M Zoumadakis; M Tabler
Journal:  Nucleic Acids Res       Date:  1995-04-11       Impact factor: 16.971

8.  Importance of independence in ribozyme reactions: kinetic behavior of trimmed and of simply connected multiple ribozymes with potential activity against human immunodeficiency virus.

Authors:  J Ohkawa; N Yuyama; Y Takebe; S Nishikawa; K Taira
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

9.  Combinatorial screening and intracellular antiviral activity of hairpin ribozymes directed against hepatitis B virus.

Authors:  J zu Putlitz; Q Yu; J M Burke; J R Wands
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

Review 10.  Targeting hepatitis B therapy to the liver. Clinical pharmacokinetic considerations.

Authors:  P C Rensen; R L de Vrueh; T J van Berkel
Journal:  Clin Pharmacokinet       Date:  1996-08       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.